BioVie Inc. (BIVI) vs Dare Bioscience, Inc. (DARE)
A side-by-side comparison of BioVie Inc. and Dare Bioscience, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BIVI
BioVie Inc.
$1.47HealthcareDelayed quote: Oct 6, 2026, 12:09 PM EDT
DARE
Dare Bioscience, Inc.
$0.84HealthcareDelayed quote: Oct 6, 2026, 12:02 PM EDT
Total return — BIVI vs DARE
growth of $100 · dividends reinvested · last 10yBIVI -100.0% (-54.2%/yr)DARE -99.3% (-39.1%/yr)DARE compounded faster over this window
Log scale — wide-divergence pair
BIVI DARE
BIVI vs DARE: by the numbers
- •DARE is the larger company ($13M vs $11M market cap).
- •Both run net losses; BIVI's is the smaller (0.00% vs -804.37% net margin).
Metrics side by side
Valuation
| Metric | BIVI | DARE |
|---|---|---|
| P/S ratio | N/A | 9.19 |
| P/B ratio | 1.08 | N/A |
Profitability
| Metric | BIVI | DARE |
|---|---|---|
| Gross margin | 0.00% | -137.55% |
| Operating margin | 0.00% | -1315.51% |
| Net margin | 0.00% | -804.37% |
| ROE | -214.92% | N/A |
| ROIC | -216.67% | -203.50% |
Growth (annualized)
| Metric | BIVI | DARE |
|---|---|---|
| Total return CAGR (5Y) | -70.37% | -46.35% |
Frequently asked
- How have BIVI and DARE total returns compared?
- Over the past 10 years, BIVI delivered -54.09% and DARE delivered -39.10% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.